Flanagan Mindy, Ramanujam Rangaraj, Sutherland Jason, Vaughn Thomas, Diekema Daniel, Doebbeling Bradley N
VA HSR&D Center for Implementing Evidence-based Practice, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana 46202, USA.
Med Care. 2007 Jun;45(6):537-44. doi: 10.1097/MLR.0b013e31803bb48b.
The rapid spread of antimicrobial resistance (AMR) in the US hospitals poses serious quality and safety problems. Expert panels, identifying strategies for optimizing antibiotic use and preventing AMR spread, have recommended hospitals undertake efforts to implement specific evidence-based practices.
To develop and validate a measurement scale for assessing hospitals' efforts to implement recommended AMR prevention and control measures.
Surveys were mailed to infection control professionals in a national sample of 670 US hospitals stratified by geographic region, bedsize, teaching status, and VA affiliation.
: Four hundred forty-eight infection control professionals participated (67% response rate).
Survey items measured implementation of guideline recommendations, practices for AMR monitoring and feedback, AMR-related outcomes (methicillin-resistant Staphylococcus aureus prevalence and outbreaks [MRSA]), and organizational features. "Derivation" and "validation" samples were randomly selected. Exploratory factor analysis was performed to identify factors underlying AMR prevention and control efforts. Multiple methods were used for validation.
We identified 4 empirically distinct factors in AMR prevention and control: (1) practices for antimicrobial prescription/use, (2) information/resources for AMR control, (3) practices for isolating infected patients, and (4) organizational support for infection control policies. The Prevention and Control of Antimicrobial Resistance scale was reliable and had content and construct validity. MRSA prevalence was significantly lower in hospitals with higher resource/information availability and broader organizational support.
The Prevention and Control of Antimicrobial Resistance scale offers a simple yet discriminating assessment of AMR prevention and control efforts. Use should complement assessment methods based exclusively on AMR outcomes.
美国医院中抗菌药物耐药性(AMR)的迅速传播带来了严重的质量和安全问题。专家小组确定了优化抗生素使用和预防AMR传播的策略,建议医院努力实施特定的循证实践。
开发并验证一种测量量表,用于评估医院在实施推荐的AMR预防和控制措施方面的努力。
向670家美国医院的全国样本中的感染控制专业人员邮寄调查问卷,这些医院按地理区域、床位规模、教学状况和退伍军人事务部附属关系进行分层。
448名感染控制专业人员参与调查(回复率67%)。
调查项目测量了指南建议的实施情况、AMR监测和反馈的实践、AMR相关结果(耐甲氧西林金黄色葡萄球菌流行率和暴发情况[MRSA])以及组织特征。随机选择“衍生”和“验证”样本。进行探索性因素分析以确定AMR预防和控制努力背后的因素。使用多种方法进行验证。
我们在AMR预防和控制中确定了4个经验上不同的因素:(1)抗菌药物处方/使用实践,(2)AMR控制的信息/资源,(3)隔离感染患者的实践,以及(4)对感染控制政策的组织支持。抗菌药物耐药性预防与控制量表可靠,具有内容效度和结构效度。在资源/信息可用性较高且组织支持较广泛的医院中,MRSA流行率显著较低。
抗菌药物耐药性预防与控制量表为AMR预防和控制努力提供了一种简单但有区分度的评估。其使用应补充仅基于AMR结果的评估方法。